Nuocheng Jianhua (09969.HK) will hold a board meeting on May 13 to approve the first quarter results

Glonghui, April 29, 丨 Nuochengjianhua (09969.HK) announced that the company will hold a board meeting on May 13, 2024 to consider and approve the unaudited first quarter results of the company and its subsidiaries for the three months ended March 31, 2024 and their announcements.

Gelonghui FinanceApr 29 04:43 ET

諾誠健華：二零二三年年報

Futu NewsApr 26 04:53 ET · Announcements

Zhitong Hong Kong Shareholders' Rights Disclosure | April 15

According to data from the Zhitong Finance App, China Jinmao (00817), Nuocheng Jianhua (09969), Sunshine 100 China (02608), BOE Precision (00710), and Anle Engineering (01977) made the latest shareholders' rights disclosure on April 15, 2024. Stock name Institutional name Change of nature of shares before change of shareholding ratio China Jinmao (00817) Zhang Hui had a good position of 4.4840 million shares 8.484 million shares 0.06% (latest) 0.03% (previous), Nuocheng Jianhua (09969) King Bridge Inves

Zhitong FinanceApr 14 20:05 ET

InnoCare Pharma Limited (HKG:9969) Surges 5.2%; Retail Investors Who Own 32% Shares Profited Along With Insiders

Key Insights Significant control over InnoCare Pharma by retail investors implies that the general public has more power to influence management and governance-related decisions The top 9 shareholde

Simply Wall StApr 7 20:48 ET

Looking for new pharmaceutical productivity: Looking at the high-quality development of local innovative pharmaceutical companies from Nuochengjianhua (9969.HK/688428.SH)

“New quality productivity” is becoming one of the most popular terms recently. In March 2024, the report on the work of the Chinese government identified “developing new quality productivity” as the top priority at present. Among them, innovative drugs are clearly mentioned for the first time in the “Actively Cultivating Emerging Industries and Future Industries” section, stating that it is necessary to “accelerate the development of the cutting-edge and emerging innovative drug industry, actively build a new growth engine for biomantry manufacturing, open up a new life science circuit, and create a number of pioneering zones for future industries” to add another spring breeze to the innovative drug circuit. Well, in an age where the innovative drug industry is receiving so much attention from top-level design, it

Gelonghui FinanceApr 2 20:26 ET

Read Nuochengjianhua's 2023 performance report in one picture

On March 28, Nuochengjianhua announced its 2023 performance report. The following will take you to read Nuochengjianhua's 2023 performance report with a picture.

Gelonghui FinanceMar 28 22:27 ET